DESCRIPTION OF BUSINESS - License and Distribution Agreements (Black Belt Therapeutics Limited) (Details) - Black Belt Therapeutics Ltd |
1 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Aug. 31, 2021
USD ($)
|
Aug. 31, 2021
EUR (€)
|
Jun. 30, 2021
USD ($)
|
Apr. 30, 2019
USD ($)
|
Apr. 30, 2019
EUR (€)
|
Dec. 31, 2021
USD ($)
|
Dec. 31, 2021
EUR (€)
|
Dec. 31, 2019
USD ($)
|
Dec. 31, 2019
EUR (€)
|
Apr. 30, 2019
EUR (€)
|
|
| Description of Business and Basis of Presentation | ||||||||||
| Upfront payment | $ 5,700,000 | € 5,000,000 | ||||||||
| Milestone payment | $ 305,000 | € 250,000 | $ 750,000 | |||||||
| In-process research and development expensed | $ 1,100,000 | € 5,000,000 | $ 1,100,000 | € 5,000,000 | ||||||
| Research and Development Asset Acquired Other than through Business Combination, Writeoff, Statement of Income or Comprehensive Income [Extensible Enumeration] | Research and Development Expense. | Research and Development Expense. | Research and Development Expense. | Research and Development Expense. | ||||||
| Development milestone payable | 2,930,000 | € 2,750,000 | ||||||||
| Sales milestone payable | $ 40,750,000 | |||||||||